Table 2 Treatment data in 226 patients with locally advanced rectal cancer
Value* | |
|---|---|
Time from diagnosis to CCRT (days) | |
Mean | 43.03 |
Range | 10-131 |
Radiation dose (Gy) | |
Mean | 49.74 |
Median | 50 |
Range | 23-54 |
% receiving ≥45 Gy | 98 |
Concurrent chemotherapy regimen, n (%) | |
Continuous infusion 5FU | 91 (40) |
Bolus 5FU | 39 (17) |
Capecitabine | 90 (40) |
Tegafur-uracil | 6 (3) |
Time from CCRT to surgery (days) | |
Mean | 41 |
Median | 36 |
Range | 28-110 |
Surgery, n (%) | |
Low anterior resection | 143 (64) |
Abdominoperineal resection | 80 (36) |
Local excision | 1 (0.4) |
Adjuvant chemotherapy, n (%) | |
None | 69 (31) |
5FU | 129 (58) |
Capecitabine | 19 (9) |
Oxaliplatin | 7 (3) |